<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2807245662
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2024
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Foscavir
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        FOSCARNET
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution for infusion
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        250
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        821.30
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="FRESENIUS KABI" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            FRESENIUS KABI
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 461]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            QOMEL MEDICAL DRUG STORE
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Clinigen Healthcare Ltd
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        QJ05AD01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Foscavir contains a medicine called foscarnet. This belongs to a group of medicines called anti-virals. It works by stopping viruses from multiplying in number.</p><p>Foscavir is used to treat the following infections that are caused by viruses:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; An eye infection caused by a virus in people with AIDS. The virus is called cytomegalovirus (CMV) and the infection is known as CMV retinitis. Foscavir stops the infection from getting worse but it cannot repair the damage that has already happened.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Herpes Simplex Virus (HSV). Foscavir is given to people with HSV who have a weakened immune system. It is given to people who have not got better from HSV after having a medicine called aciclovir.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not have Foscavir:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are allergic (hypersensitive) to foscarnet or any of the other ingredients of this medicine (listed in section 6).</p><p>If you are not sure, talk to your doctor or nurse before having Foscavir.</p><p>&nbsp;</p><p><strong>Warnings and precautions</strong></p><p>Talk to your doctor or nurse before you have Foscavir.&nbsp;</p><p>&nbsp;</p><p>Check with your doctor or nurse before having Foscavir if:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You have problems with your kidneys.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You have problems with your heart.</p><p>If you are not sure if this applies to you, talk to your doctor or nurse before having Foscavir.</p><p>&nbsp;</p><p><strong>Other medicines and Foscavir</strong></p><p>Tell your doctor or nurse if you are taking, have recently taken or might take any other medicines. This includes medicines that you buy without a prescription and herbal medicines. This is because Foscavir can affect the way some medicines work, and some medicines can have an effect on Foscavir.</p><p>&nbsp;</p><p>In particular, tell your doctor or nurse if you are already having any of the following medicines:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pentamidine (for infections).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Amphotericin B (for fungal infections).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Aciclovir (for viral infections).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Antibiotics called aminoglycosides, such as gentamicin and streptomycin (for infections).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ciclosporin A, methotrexate or tacrolimus (used to suppress the immune system).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines called protease inhibitors, such as ritonavir and saquinavir.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Laxatives.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Quinidine, amiodarone, sotalol or any other medicines which may affect your heart rate or rhythm.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tranquilisers (neuroleptics).</p><p>&nbsp;</p><p><strong>Pregnancy and breast-feeding</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Foscavir is not recommended during pregnancy.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Trying to become pregnant during Foscavir therapy is not recommended so you should use effective contraception methods.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Men treated with Foscavir should not father a child during or up to 6 months after therapy.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not have Foscavir if you are breast-feeding.</p><p>&nbsp;</p><p><strong>Driving and using machines</strong></p><p>Foscavir may affect you being able to drive or use tools or machines. Talk to your doctor before you do any of these activities.</p><p>&nbsp;</p><p><strong>Tests before and during your treatment with Foscavir</strong></p><p>Your doctor may do blood and urine tests before and during your treatment with Foscavir. This is to check how well your kidneys are working and the level of minerals in your blood.</p><p><strong>&nbsp;</strong></p><p><strong>Foscavir contains sodium</strong></p><p>The maximum recommended daily dose of this medicinal product contains 2.75 g sodium (found in table salt). This is equivalent to 138% of the adult recommended maximum daily dietary intake for sodium.</p><p>Talk to your pharmacist or doctor if you need Foscavir on a daily basis for a prolonged period of time, especially if you have been advised to follow a low salt diet.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Foscavir will be given to you by a doctor or nurse. It will be given to you as an infusion (drip) into a vein. It may be given into a central line in your chest if you already have one in place.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Each infusion will take at least 1 hour. Do not interfere with your drip during the infusion.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The amount of Foscavir that you are given depends on how well your kidneys are working. It also depends on your weight.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; It is important to have plenty of fluid with the infusion. This will help to prevent kidney problems. If you need fluid, the doctor or nurse will give it to you at the same time as Foscavir.</p><p><strong>&nbsp;</strong></p><p><strong>Having Foscavir for CMV retinitis</strong></p><p>If you are having Foscavir for CMV retinitis, there will be two stages to your treatment. The first stage is called induction therapy and the second stage is called maintenance therapy.</p><p><strong>Induction therapy</strong></p><ul><li>During induction therapy, you will be given an infusion every 8 hours. This will usually happen for 2 or 3 weeks.</li><li>The usual dose for induction therapy is 60 mg of Foscavir for every kilogram that you weigh (60 mg/kg).</li></ul><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Your doctor will tell you when you are ready to change to maintenance therapy.</p><p><strong>Maintenance therapy</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; During maintenance therapy, you will be given an infusion once a day.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The usual dose for maintenance therapy is 60 to 120 mg of Foscavir for every kilogram that you weigh (60 to 120 mg/kg).</p><p>Your doctor will tell you if you need to have more or less Foscavir and how often you should have it. This is so that you have the dose that is right for you.</p><p>Sometimes your doctor may ask you to have a medicine called ganciclovir as well. This is to make sure that you have the treatment that is right for you.</p><p>&nbsp;</p><p><strong>Having Foscavir for Herpes Simplex Virus</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are being given Foscavir to treat Herpes Simplex Virus, there is only one stage.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You will be given an infusion every 8 hours.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Your wounds (lesions) may start to heal after about 1 week. However, you may need to keep having Foscavir for 2 to 3 weeks or until your wounds have healed.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The usual dose is 40 mg of Foscavir for every kilogram that you weigh (40 mg/kg).</p><p>&nbsp;</p><p><strong>Personal hygiene</strong></p><p>Wash your genitals carefully after passing water (urine). This will help to prevent any sores from developing.</p><p>&nbsp;</p><p><strong>If you get Foscavir solution on your skin or in your eyes</strong></p><p>If you get Foscavir solution on your skin or in your eyes by mistake, rinse your skin or your eyes straight away with water.</p><p>&nbsp;</p><p><strong>If you think you have been given too much Foscavir</strong></p><p>If you think you have been given too much Foscavir, talk to your doctor straight away.</p><p><strong>&nbsp;</strong></p><p><strong>If you forget to have Foscavir</strong></p><p>If you think you have missed a dose, talk to your doctor straight away.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p><strong>Some side effects can be serious and need immediate medical attention:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severe allergic reactions including a fall in blood pressure, shock and swelling of the skin (angioedema).&nbsp; They are known as hypersensitivity, anaphylactic or anaphylactoid reactions.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severe skin rashes. These types of rashes can be associated with redness, swelling, and blisters of the skin, mouth, throat, eyes and other places inside the body and can sometimes result in death. They are called erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis.</p><p><strong>If you get any of the above, tell your doctor straight away or go to the nearest emergency unit.</strong></p><p><strong>&nbsp;</strong></p><p><strong>Other side effects include: </strong></p><p>&nbsp;</p><p><strong>Very common (affects more than 1 in 10 people)</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Loss of appetite.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Diarrhoea.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Feeling or being sick.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Feeling weak or tired.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; High temperature or chills.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Feeling dizzy.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Headache.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pins and needles.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Skin rash.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes in how well your kidneys are working (shown in blood tests).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Low levels of white blood cells. The signs include infections and high temperature (fever).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes to red blood cells (shown in blood tests). This may make you feel tired or look pale.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; An imbalance of salts and minerals in your blood. The signs include weakness, cramps, thirst, tingling or itching of the skin and twitching of muscles.</p><p><strong>&nbsp;</strong></p><p><strong>Common (affects less than 1 in 10 people)</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pain in the tummy (abdomen), constipation, indigestion or gastrointestinal bleeding.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflamed pancreas (pancreatitis) or changes in how well your pancreas is working. The signs include severe stomach pain and there may be changes that are shown in blood tests.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Feeling anxious, nervous, depressed, agitated, aggressive or confused.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Problems with your co-ordination.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fits (convulsions).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reduced feeling in the skin.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Itchy skin.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Generally feeling unwell.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Swelling of the feet and legs.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pounding heart beat (palpitations) or change in rhythm e.g. torsade de pointes or tachycardia.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; High blood pressure.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Low blood pressure. This may make you feel dizzy.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes in tests that show how well your heart is working (ECGs).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Muscle problems. These include changes that are shown in blood tests and painful, sore, weak or twitching muscles.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Shaking (tremors).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nerve damage that may cause changes in sensation or muscle weakness (neuropathy).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Swelling, pain and redness along a vein or where the injection needle is inserted.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Genital sores.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes in how well your liver is working (shown in blood tests).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Low levels of platelets in your blood. This may make you bruise more easily.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Infection of the blood.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Kidney problems. These include pain in your kidneys (you may feel this in your lower back) and kidney failure. There may be changes that are shown in blood or water (urine) tests.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pain when you pass water (urine).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Passing water (urine) more often than normal. Rarely, you may also feel very thirsty or dehydrated.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pain in your chest.</p><p><strong>&nbsp;</strong></p><p><strong>Uncommon (affects less than 1 in 100 people)</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; An itchy rash (urticaria).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Too much acid in the blood. This may make you breathe more quickly.</p><p><strong>&nbsp;</strong></p><p><strong>The following side effects have also been reported (frequency not known)</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Unusual heart beat.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; An ulcer in your oesophagus (the passage where food travels from the throat to the stomach).&nbsp; This may be painful.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severe muscle problems with a breakdown of your muscle tissue (rhabdomyolysis). The signs include abnormal urine colour and severe muscle weakness, tenderness or stiffness.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Blood in your water (urine).</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Keep this medicine out of the sight and reach of children.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not use this medicine after the expiry date which is stated on the label. The expiry date refers to the last day of that month.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not store unopened bottles of Foscavir above 25&deg;C. Do not put them in the fridge.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Foscavir may be mixed with another liquid by a pharmacist. This is to give you a medicine ready to use. The pharmacist will tell you how to store it and when to use it by.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <ul><li>The active substance is foscarnet. There is 24 mg of foscarnet in each millilitre (ml) of solution.</li><li>The other ingredients are water for injection and hydrochloric acid (E507).</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Foscavir is a sterile solution for infusion.  The solution is clear and colourless. Foscavir comes in bottles containing 250 ml.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Marketing Authorisation Holder and Manufacturer</p><p>&nbsp;</p><p>Clinigen Healthcare Ltd.,</p><p>Pitcairn House, First Avenue,</p><p>Burton-on-Trent,</p><p>Staffordshire, DE14 2WW, UK.</p><p>&nbsp;</p><p>Manufacturer</p><p>&nbsp;</p><p>Fresenius Kabi Austria GmbH,</p><p>Hafnerstrasse 36,</p><p>A-8055 Graz, Austria.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in March 2022.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>يحتوي فوسكافير على دواء يسمى فوسكارنيت. هذا ينتمي إلى مجموعة من الأدوية تسمى مضادات الفيروسات. إنه يعمل عن طريق منع الفيروسات من التكاثر في العدد.</p><p>يستخدم فوسكافير لعلاج الالتهابات التالية التي تسببها الفيروسات:</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدوى بالعين يسببها فيروس يصيب المصابين بمرض الإيدز. يسمى الفيروس بالفيروس المضخم للخلايا (CMV) وتعرف العدوى باسم التهاب الشبكية المضخم للخلايا. يمنع فوسكافير العدوى من التفاقم لكنه لا يستطيع إصلاح الضرر الذي حدث بالفعل.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فيروس الهربس البسيط (HSV). يتم إعطاء فوسكافير للأشخاص المصابين بفيروس الهربس البسيط والذين يعانون من ضعف في جهاز المناعة. يتم إعطاؤه للأشخاص الذين لم تتحسن حالتهم من فيروس الهربس البسيط بعد تناول دواء يسمى أسيكلوفير.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>لا تأخذ فوسكافير في اي من الحالات التالية :</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من حساسية تجاه فوسكارنيت أو أي من مكونات فوسكافير الأخرى (المدرجة في القسم 6).</p><p>إذا لم تكن متأكدًا ، تحدث إلى طبيبك أو ممرضتك قبل تناول فوسكافير.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p dir="RTL"><strong>المحاذير والإحتياطات :</strong></p><p dir="RTL">&nbsp;</p><p>تحدث إلى طبيبك أو الصيدلي أو الممرضة قبل تناول فوسكافير في اي من الحالات التالية:</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لديك مشاكل في الكلى.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لديك مشاكل في القلب.</p><p>إذا لم تكن متأكدًا مما إذا كان أي مما سبق ينطبق عليك &nbsp;عليك التحدث إلى طبيبك أو الصيدلي قبل تناول فوسكافير.</p><p>&nbsp;</p><p dir="RTL"><strong>الأدوية الأخرى وفوسكافير :</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أخبر طبيبك أو ممرضتك إذا كنت تتناول أو تناولت مؤخرًا أو قد تتناول أي أدوية أخرى. يشمل ذلك الأدوية التي تشتريها بدون وصفة طبية والأدوية العشبية. وذلك لأن فوسكافير يمكن أن يؤثر على طريقة عمل بعض الأدوية ، وبعض الأدوية يمكن أن يكون لها تأثير على فوسكافير.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وعلى وجه الخصوص أخبر طبيبك أو الممرضة أو الصيدلي إذا كنت تتناول أيًا مما يلي:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بنتاميدين (للالتهابات).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أمفوتريسين ب (للإلتهابات الفطرية).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أسيكلوفير (للالتهابات الفيروسية).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المضادات الحيوية التي تسمى أمينوغليكوزيدات ، مثل الجنتاميسين والستربتومايسين (للعدوى).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سيكلوسبورين أ ، ميثوتريكسات أو تاكروليموس (تستخدم لتثبيط جهاز المناعة).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تسمى مثبطات الأنزيم البروتيني ، مثل ريتونافير وساكوينافير.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الملينات.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كينيدين ، أميودارون ، سوتالول أو أي أدوية أخرى قد تؤثر على معدل ضربات القلب أو انتظام ضربات القلب.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المهدئات (مضادات الذهان)..</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</p><p dir="RTL"><strong>الحمل والإرضاع والخصوبة :</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا ينصح باستخدام فوسكافير أثناء الحمل.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا ينصح بمحاولة الحمل أثناء العلاج بـ فوسكافير لذا يجب عليك استخدام وسائل منع الحمل الفعالة.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب على الرجال الذين عولجوا باستخدام فوسكافير عدم الإنجاب خلال أو حتى 6 أشهر بعد العلاج.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تستخدمي فوسكافير إذا كنت مرضعة.</p><p>&nbsp;</p><p dir="RTL"><strong>قيادة السيارات وتشغيل الآليات :</strong></p><p>قد يؤثر فوسكافير على قدرتك على القيادة أو استخدام الأدوات أو الآلات. تحدث إلى طبيبك قبل القيام بأي من هذه الأنشطة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الاختبارات قبل وأثناء العلاج باستخدام فوسكافير:</strong></p><p>قد يقوم طبيبك بإجراء فحوصات الدم والبول قبل وأثناء العلاج بفوسكافير. هذا للتحقق من مدى كفاءة عمل كليتيك ومستوى المعادن في دمك.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>يحتوي فوسكافير على الصوديوم:</strong></p><p>الحد الأقصى للجرعة اليومية الموصى بها من هذا المستحضر تحتوي على 2.75 جرام من الصوديوم (موجود في ملح الطعام). وهذا يعادل 138٪ من الحد الأقصى للجرعة الغذائية اليومية الموصى بها للبالغين من الصوديوم.</p><p>تحدث إلى الصيدلي أو الطبيب إذا كنت بحاجة إلى فوسكافير بشكل يومي لفترة طويلة من الزمن ، خاصة إذا تم نصحك باتباع نظام غذائي قليل الملح.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سوف يتم إعطاؤك فوسكافير من قبل طبيب أو ممرضة. سيتم إعطاؤه لك على شكل تسريب (بالتنقيط) في الوريد. قد يتم إعطاؤه في خط مركزي في صدرك إذا كان لديك بالفعل واحدًا في مكانه.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سيستغرق كل تسريب ساعة واحدة على الأقل. لا تتدخل في التنقيط أثناء التسريب.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تعتمد كمية فوسكافير التي يتم إعطاؤها لك على مدى جودة عمل كليتيك. كما أنه يعتمد على وزنك.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; من المهم أن يكون لديك الكثير من السوائل مع التسريب. هذا سوف يساعد على منع مشاكل الكلى. إذا كنت بحاجة إلى سوائل ، فسوف يعطيك الطبيب أو الممرضة ذلك في نفس وقت تناول فوسكافير.</p><p><strong>&nbsp;</strong></p><p dir="RTL"><strong>وجود فوسكافير لعلاج التهاب الشبكية المضخم للخلايا:</strong></p><p>إذا كنت تتناول فوسكافير لعلاج التهاب الشبكية المضخم للخلايا ، فستكون هناك مرحلتان في علاجك. تسمى المرحلة الأولى العلاج التعريفي والمرحلة الثانية تسمى العلاج الوقائي.</p><p dir="RTL"><strong>العلاج التعريفي:</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أثناء العلاج التعريفي ، سيتم إعطاؤك حقنة في الوريد كل 8 ساعات. سيحدث هذا عادة لمدة أسبوعين أو ثلاثة أسابيع.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الجرعة المعتادة للعلاج التعريفي هي 60 ملغم فوسكافير لكل كيلو جرام (60 ملغم/ كجم).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سيخبرك طبيبك عندما تكون مستعدًا للتغيير إلى علاج الوقائي.</p><p>&nbsp;</p><p dir="RTL">&nbsp; <strong>العلاج الوقائي:</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أثناء العلاج الوقائي ، سيتم إعطاؤك حقنة مرة واحدة في اليوم.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الجرعة المعتادة للعلاج الوقائي هي 60 إلى 120 ملغم من فوسكافير لكل كيلو جرام</p><p>(60 إلى 120 ملغم/ كجم).</p><p>سيخبرك طبيبك إذا كنت بحاجة إلى كمية أكبر أو أقل من فوسكافير وكم مرة يجب أن تتناولها. هذا حتى تحصل على الجرعة المناسبة لك.</p><p>قد يطلب منك طبيبك أحيانًا تناول دواء يسمى جانسايكلوفير أيضًا. هذا للتأكد من حصولك على العلاج المناسب لك.</p><p>&nbsp;</p><p dir="RTL"><strong>تناول فوسكافير لفيروس الهربس البسيط:</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا تم إعطاؤك فوسكافير لعلاج فيروس الهربس البسيط ، فهناك مرحلة واحدة فقط.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سيتم إعطاؤك حقنة في الوريد كل 8 ساعات.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد تبدأ جروحك (التقرحات) في الإلتئام بعد حوالي أسبوع. ومع ذلك ، قد تحتاج إلى الاستمرار في تناول فوسكافير لمدة 2 إلى 3 أسابيع أو حتى تلتئم جروحك.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الجرعة المعتادة هي 40 مجم من فوسكافير عن كل كيلو جرام تزن (40 ملغم/ كجم).</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>النظافة الشخصية:</strong></p><p>إغسل أعضائك التناسلية بعناية بعد التبول. سيساعد ذلك على منع ظهور أي تقرحات.</p><p>&nbsp;</p><p dir="RTL"><strong>إذا وضعت محلول فوسكافير على بشرتك أو في عينيك:</strong></p><p>إذا وضعت محلول فوسكافير على بشرتك أو في عينيك عن طريق الخطأ ، اشطف بشرتك أو عينيك على الفور بالماء</p><p>&nbsp;</p><p dir="RTL"><strong>إذا كنت تعتقد أنك قد أخذت الكثير من فوسكافير:</strong></p><p>إذا كنت تعتقد أنك قد أخذت الكثير من فوسكافير ، فتحدث إلى طبيبك على الفور.</p><p>&nbsp;</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>إذا نسيت أخذ فوسكافير:</strong></p><p>إذا كنت تعتقد أنك فاتتك جرعة ، فتحدث إلى طبيبك على الفور.</p><p>&nbsp;</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جميع الأدوية الأخرى يمكن أن يسبب المستحضر تأثيرات جانبية مع انها لا تحدث لدى جميع من يستخدمون هذا الدواء.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>قد تكون بعض الآثار الجانبية خطيرة وتحتاج إلى عناية طبية فورية:</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ردود فعل تحسسية شديدة بما في ذلك انخفاض في ضغط الدم وصدمة وانتفاخ الجلد (تورم). تُعرف باسم فرط الحساسية أو تفاعلات الحساسية أو الحساسية.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي شديد. يمكن أن تترافق هذه الأنواع من الطفح الجلدي مع احمرار وتورم وبثور في الجلد والفم والحلق والعينين وأماكن أخرى داخل الجسم ويمكن أن تؤدي في بعض الأحيان إلى الوفاة. وهي تسمى الحُمامى مُتعدِّدة الأشكال ومتلازمة ستيفنز جونسون وتقشر البشرة السمي.</p><p><strong>إذا أصبت بأي من الآثار الجانبية المذكورة أعلاه، أخبر طبيبك على الفور أو اذهب إلى أقرب وحدة طوارئ.</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تشمل الآثار الجانبية الأخرى</strong>:</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تأثيرات جانبية شائعة جدًا(تظهر لدى أكثر من 1 من بين كل 10 أشخاص) :</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان الشهية.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إسهال.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالمرض.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالضعف أو التعب.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع في درجة الحرارة أو قشعريرة.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالدوار.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صداع الراس.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بدبابيس وإبر.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الطفح الجلدي.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التغييرات في مدى كفاءة عمل الكليتين (موضحة في فحوصات الدم).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض مستويات خلايا الدم البيضاء. تشمل العلامات العدوى وارتفاع درجة الحرارة (الحمى).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغييرات في خلايا الدم الحمراء (موضحة في فحوصات الدم). قد يجعلك هذا تشعر بالتعب أو تبدو شاحبًا.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; خلل في الأملاح والمعادن في دمك. وتشمل العلامات ضعف وتشنجات وعطش ووخز أو حكة في الجلد وارتعاش في العضلات.</p><p>&nbsp;</p><p dir="RTL"><strong>تأثيرات</strong><strong> </strong><strong>جانبية</strong><strong> </strong><strong>شائعة</strong><strong> ( </strong><strong>تظهر</strong><strong> </strong><strong>لدى</strong><strong> </strong><strong>اقل</strong><strong> </strong><strong>من</strong><strong> </strong><strong>شخص</strong><strong> </strong><strong>بين</strong><strong> </strong><strong>كل</strong><strong> 10 </strong><strong>أشخاص</strong><strong>) :</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في البطن أو إمساك أو عسر هضم أو نزيف معدي معوي.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب في البنكرياس (التهاب البنكرياس) أو تغيرات في مدى جودة عمل البنكرياس. تشمل العلامات آلامًا شديدة في المعدة وقد تكون هناك تغييرات تظهر في اختبارات الدم.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالقلق أو العصبية أو الاكتئاب أو الغضب أو العدوانية أو الارتباك.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل في التنسيق الخاص بك.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النوبات (التشنجات).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قلة الإحساس بالجلد.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حكة في الجلد.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بتوعك بشكل عام.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم القدمين والساقين.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; خفقان القلب (الخفقان) أو تغير في انتظام ضربات القلب، على سبيل المثال مُتلازمة QT الطويلة أو عدم انتظام ضربات القلب.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع ضغط الدم.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض ضغط الدم. قد يجعلك هذا تشعر بالدوار.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التغييرات في الاختبارات التي تظهر مدى جودة عمل قلبك (ECGs).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل العضلات. وتشمل هذه التغييرات التي تظهر في اختبارات الدم وألم وضعف وتشنج العضلات.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الرعشة (الرعشات).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تلف الأعصاب الذي قد يسبب تغيرات في الإحساس أو ضعف العضلات (الاعتلال العصبي).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم وألم واحمرار على طول الوريد أو مكان إدخال إبرة الحقن.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تقرحات في الأعضاء التناسلية.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغييرات في مدى كفاءة عمل الكبد (موضحة في اختبارات الدم).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض مستويات الصفيحات الدموية في الدم. هذا قد يجعلك تصاب بالكدمات بسهولة أكبر.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدوى في الدم.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل في الكلى. وتشمل هذه الآلام في الكلى (قد تشعر بهذا في أسفل الظهر) والفشل الكلوي. قد تكون هناك تغييرات تظهر في اختبارات الدم أو الماء (البول).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم عند التبول.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; خروج الماء (البول) أكثر من المعتاد. في حالات نادرة ، قد تشعر أيضًا بالعطش الشديد أو الجفاف.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في صدرك.</p><p>&nbsp;</p><p dir="RTL"><strong>تأثيرات جانبية غير شائعة: ( تظهر لدى اقل من شخص من بين كل 100 شخص) :</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي مثير للحكة (شرى).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة الحموضة في الدم. قد يجعلك هذا تتنفس بسرعة أكبر.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>تم الإبلاغ أيضًا عن الآثار الجانبية التالية (شيوعها غير معروف):</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضربات قلب غير عادية.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قرحة في المريء (الممر الذي ينتقل فيه الطعام من الحلق إلى المعدة). قد يكون هذا مؤلمًا.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل عضلية خطيرة مع انهيار الأنسجة العضلية (انحلال الربيـدات أو انحلال العضلات المخططـة الهيكليـة). تشمل العلامات لون بول غير طبيعي وضعف شديد في العضلات أو ألم أو تصلب.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; دم في الماء (البول).</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احفظ هذا الدواء بعيدًا عن رؤية ومتناول أيدي الأطفال.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المدون على الملصق. يشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من نفس الشهر.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تخزن زجاجات غير مفتوحة من فوسكافير فوق 25 درجة مئوية. لا تضعهم في الثلاجة.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يمكن خلط فوسكافير مع سائل آخر بواسطة الصيدلي. هذا لإعطائك دواء جاهزًا للاستخدام. سيخبرك الصيدلي بكيفية تخزينه ومتى تستخدمه.</p><p>&bull; لا تتخلص من الأدوية في مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. ستساعد هذه الإجراءات في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المادة الفعالة هي فوسكارنت يوجد 24 مجم من فوسكارنت في كل مليلتر من المحلول.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المكونات الأخرى هي ماء للحقن وحمض الهيدروكلوريك (E507).</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>فوسكافير هو محلول معقم للتسريب. الحل واضح وعديم اللون. يأتي فوسكافير في عبوات تحتوي على 250 مل.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>ج</strong><strong>. </strong><strong>حامل</strong><strong> </strong><strong>رخصة</strong><strong> </strong><strong>التسويق</strong><strong>&nbsp; </strong></p><p dir="RTL">&nbsp;</p><p>كلينجين هيلث كير إل تي دي ،</p><p>بيت بيتكيرن ، الجادة الأولى ،</p><p>بيرتون أون ترينت ،</p><p>ستافوردشاير ، DE14 2WW ،</p><p>المملكة المتحدة</p><p>&nbsp;</p><p dir="RTL"><strong>د</strong><strong>. </strong><strong>الشركه</strong><strong> </strong><strong>الصانعه</strong><strong> </strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">فريزنس كابي النمسا جي ام بي اتش</p><p dir="RTL">Hafnerstrasse 36 ،</p><p dir="RTL">A-8055 جراتس ، النمسا.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
             تمت اخر مراجعه للنشره في شهر مارس 2022 
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Foscavir 24 mg/ml Solution for Infusion
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Foscarnet trisodium hexahydrate 24 mg/ml. 	
For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solution for infusion.
Clear and colourless solution.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Foscavir is indicated for induction and maintenance therapy of cytomegalovirus (CMV) retinitis in patients with AIDS.</p><p dir="ltr">Foscavir is also indicated for the treatment of mucocutaneous Herpes Simplex Virus (HSV) infections, clinically unresponsive to aciclovir in immunocompromised patients.&nbsp; The safety and efficacy of Foscavir for the treatment of other HSV infections (e.g. retinitis, encephalitis); congenital or neonatal disease; or HSV in immunocompetent individuals has not been established.</p><p dir="ltr">The diagnosis of aciclovir unresponsiveness can be made either clinically by treatment with intravenous aciclovir (5&ndash;10&nbsp;mg/kg t.i.d) for 10 days without response or by <em>in vitro</em> testing.</p><p dir="ltr">Foscavir is not recommended for treatment of CMV infections other than retinitis or HSV or for use in non-AIDS or non-immunocompromised patients.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr"><strong>Method of administration:</strong>&nbsp; Foscarnet should be administered by the intravenous route only, either by a central venous line or in a peripheral vein.&nbsp;</p><p dir="ltr">When peripheral veins are used, the solution of foscarnet 24&nbsp;mg/ml must be diluted.&nbsp; Individually dispensed doses of foscarnet should be aseptically transferred and diluted with equal parts of 0.9% sodium chloride (9&nbsp;mg/ml) or 5% dextrose (50&nbsp;mg/ml) by the hospital pharmacy.&nbsp; The diluted solutions should be used as soon as possible after preparation but can be stored for up to 24 hours if kept refrigerated.</p><p dir="ltr">The solution of foscarnet 24&nbsp;mg/ml may be given without dilution via a central vein.</p><p dir="ltr"><strong>Adults:</strong>&nbsp; Induction therapy for CMV retinitis:<strong><em>&nbsp; </em></strong>Foscavir is administered over 2&ndash;3 weeks depending on the clinical response, as intermittent infusions every 8 hours at a dose of 60&nbsp;mg/kg in patients with normal renal function.&nbsp; Dosage must be individualised for patient&rsquo;s renal function (see dosing chart below).&nbsp; The infusion time should not be shorter than 1 hour.</p><p dir="ltr"><strong><em>Maintenance therapy:</em></strong><em> </em>&nbsp;For maintenance therapy, following induction therapy of CMV retinitis, Foscavir is administered seven days a week as long as therapy is considered appropriate.&nbsp; In patients with normal renal function, it is recommended to initiate therapy at 60 mg/kg.&nbsp; Increase to a dose of 90&ndash;120 mg/kg may then be considered in patients tolerating the initial dose level and/or those with progressive retinitis.&nbsp; A number of patients have received 90 mg/kg over a 2 hour period as a starting dose for maintenance therapy.&nbsp; Dosage must be reduced in patients with renal insufficiency (see dosage chart at end of dosage section).</p><p dir="ltr">Patients who experience progression of retinitis while receiving maintenance therapy may be re-treated with the induction regimen.&nbsp;</p><p dir="ltr"><strong><em>Induction therapy of mucocutaneous HSV infections unresponsive to aciclovir: </em></strong>Foscavir is administered for 2&ndash;3 weeks or until healing of lesions, as intermittent infusions at a dose of 40&nbsp;mg/kg over one hour every 8 hours in patients with normal renal function.&nbsp; Dosage must be individualised for patients renal function (see dosing chart below).&nbsp; The infusion time should not be shorter than 1 hour.</p><p dir="ltr">Efficacy of Foscavir maintenance therapy following induction therapy of aciclovir unresponsive HSV infections has not been established.</p><p dir="ltr"><strong>Caution:&nbsp; Do not administer Foscavir by rapid intravenous injection.</strong></p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong>&nbsp;</strong></p><p dir="ltr"><strong>Table 1&nbsp; Foscavir Dosing Chart</strong></p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong>Induction Therapy</strong></p><table border="0" cellspacing="0" cellpadding="0" dir="ltr" style="width:520px"><tbody><tr><td style="vertical-align:top"><p>Creatinine Clearance (ml/kg/min)</p></td><td style="vertical-align:top"><p>CMV</p><p>Every 8 Hours (mg/kg)</p></td><td style="vertical-align:top"><p>HSV</p><p>Every 8 Hours (mg/kg)</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;&nbsp;&nbsp; &gt; 1.6</p></td><td style="vertical-align:top"><p>60</p></td><td style="vertical-align:top"><p>40</p></td></tr><tr><td style="vertical-align:top"><p>1.6&ndash;1.4</p></td><td style="vertical-align:top"><p>55</p></td><td style="vertical-align:top"><p>37</p></td></tr><tr><td style="vertical-align:top"><p>1.4&ndash;1.2</p></td><td style="vertical-align:top"><p>49</p></td><td style="vertical-align:top"><p>33</p></td></tr><tr><td style="vertical-align:top"><p>1.2&ndash;1.0</p></td><td style="vertical-align:top"><p>42</p></td><td style="vertical-align:top"><p>28</p></td></tr><tr><td style="vertical-align:top"><p>1.0&ndash;0.8</p></td><td style="vertical-align:top"><p>35</p></td><td style="vertical-align:top"><p>24</p></td></tr><tr><td style="vertical-align:top"><p>0.8&ndash;0.6</p></td><td style="vertical-align:top"><p>28</p></td><td style="vertical-align:top"><p>19</p></td></tr><tr><td style="vertical-align:top"><p>0.6&ndash;0.4</p></td><td style="vertical-align:top"><p>21</p></td><td style="vertical-align:top"><p>14</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;&nbsp;&nbsp; &lt; 0.4</p></td><td colspan="2" style="vertical-align:top"><p>Treatment not recommended</p></td></tr></tbody></table><p dir="ltr"><strong>&nbsp;</strong></p><p dir="ltr"><strong>CMV Maintenance Therapy</strong></p><p dir="ltr"><strong>&nbsp;</strong></p><table border="1" cellspacing="0" cellpadding="0" dir="ltr" style="width:520px"><tbody><tr><td style="vertical-align:top"><p>Creatinine Clearance (ml/kg/min)</p></td><td style="vertical-align:top"><p>One Infusion Dose</p><p>(mg/kg/day in not less than one hour)</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;&nbsp;&nbsp; &gt; 1.6</p></td><td style="vertical-align:top"><p>60*</p></td></tr><tr><td style="vertical-align:top"><p>1.6&ndash;1.4</p></td><td style="vertical-align:top"><p>55</p></td></tr><tr><td style="vertical-align:top"><p>1.4&ndash;1.2</p></td><td style="vertical-align:top"><p>49</p></td></tr><tr><td style="vertical-align:top"><p>1.2&ndash;1.0</p></td><td style="vertical-align:top"><p>42</p></td></tr><tr><td style="vertical-align:top"><p>1.0&ndash;0.8</p></td><td style="vertical-align:top"><p>35</p></td></tr><tr><td style="vertical-align:top"><p>0.8&ndash;0.6</p></td><td style="vertical-align:top"><p>28</p></td></tr><tr><td style="vertical-align:top"><p>0.6&ndash;0.4</p></td><td style="vertical-align:top"><p>21</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;&nbsp;&nbsp; &lt; 0.4</p></td><td style="vertical-align:top"><p>Treatment not recommended</p></td></tr></tbody></table><p dir="ltr">*A number of patients have received 90 mg/kg as a starting dose for maintenance therapy.</p><p dir="ltr">Foscavir is not recommended in patients undergoing haemodialysis since dosage guidelines have not been established.</p><p dir="ltr">Hydration:<strong>&nbsp; </strong>Renal toxicity of Foscavir can be reduced by adequate hydration of the patient.&nbsp; It is recommended to establish diuresis by hydration with 0.5&ndash;1.0 litre of normal saline at each infusion. In compliant patients, oral hydration with similar hydration regimens has been used. Clinically dehydrated patients should have their condition corrected before initiating Foscavir therapy.</p><p dir="ltr"><strong>Elderly:</strong>&nbsp; As for adults.</p><p dir="ltr"><strong>Paediatric population:</strong> The safety and efficacy of foscarnet in children have not been established.&nbsp; Please refer to sections 4.4 and 5.3.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong>Renal or hepatic insufficiency:</strong>&nbsp; The dose must be reduced in patients with renal insufficiency according to the creatinine clearance level as described in the table above.&nbsp; Dose adjustment is not required in patients with hepatic insufficiency.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Foscavir should be used with caution in patients with reduced renal function. Since renal function impairment may occur at any time during Foscavir administration, serum creatinine should be monitored every second day during induction therapy and once weekly during maintenance therapy and appropriate dose adjustments should be performed according to renal function. Adequate hydration should be maintained in all patients (see section 4.2).&nbsp; The renal function of patients with renal disease or receiving concomitant treatment with other nephrotoxic medicinal products must be closely monitored (see section 4.5).</p><p dir="ltr">&nbsp;</p><p dir="ltr">This medicinal product contains 1.38 g of sodium per 250 ml bottle, equivalent to 69% of the WHO recommended maximum daily intake of 2 g sodium for an adult.</p><p dir="ltr">The maximum recommended daily dose of this product is 12 g of Foscavir per day (180&nbsp;mg/kg/day in average 70 kg male), which is equivalent to 138% of the WHO&nbsp; recommended maximum daily dietary intake for sodium.</p><p dir="ltr">Foscavir is considered high in sodium. This should be particularly taken into account for those on a low sodium diet. Its use should be avoided when a saline load cannot be tolerated (e.g. in cardiomyopathy).</p><p dir="ltr">&nbsp;</p><p dir="ltr">Due to Foscavir&rsquo;s propensity to chelate bivalent metal ions, such as calcium, Foscavir administration may be associated with an acute decrease of ionised serum calcium proportional to the rate of Foscavir infusion, which may not be reflected in total serum calcium levels. The electrolytes, especially calcium and magnesium, should be assessed prior to and during Foscavir therapy and deficiencies corrected.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Foscarnet has been associated with cases of prolongation of QT interval and more rarely with cases of torsade de pointes (see section 4.8). Patients with known existing prolongation of cardiac conduction intervals, particularly QTc, patients with significant electrolyte disturbances (hypokalaemia, hypomagnesaemia), bradycardia, as well as patients with underlying cardiac diseases such as congestive heart failure or who are taking medications known to prolong the QT interval should be carefully monitored due to increased risk of ventricular arrhythmia. Patients should be advised to promptly report any cardiac symptoms.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Foscavir is deposited in teeth, bone and cartilage. Animal data show that deposition is greater in young animals. The safety of Foscavir and its effect on skeletal development have not been investigated in children. Please refer to section 5.3.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Seizures, related to alterations in plasma minerals and electrolytes, have been associated with Foscavir treatment. Cases of status epilepticus have been reported.&nbsp; Therefore, patients must be carefully monitored for such changes and their potential sequelae. Mineral and electrolyte supplementation may be required.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Foscavir is excreted in high concentrations in the urine and may be associated with significant genital irritation and/or ulceration. To prevent irritation and ulceration, close attention to personal hygiene is recommended and cleaning of the genital area<em> </em>after each micturition is recommended.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Should patients experience extremity paraesthesia or nausea, it is recommended to reduce the speed of infusion.</p><p dir="ltr">&nbsp;</p><p dir="ltr">When diuretics are indicated, thiazides are recommended.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Development of resistance:&nbsp; If the administration of Foscavir does not lead to a therapeutic response or leads to a worsened condition after an initial response, this may result from a reduced sensitivity of viruses towards foscarnet.&nbsp; In this case, termination of Foscavir therapy and a change to an appropriate other medicinal product should be considered.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Since Foscavir can impair renal function, additive toxicity may occur when used in combination with other nephrotoxic drugs such as aminoglycosides, amphotericin B, ciclosporin A, aciclovir, methotrexate and tacrolimus. &nbsp;Moreover, since Foscavir can reduce serum levels of ionised calcium, extreme caution is advised when used concurrently with other drugs known to influence serum calcium levels, like i.v. pentamidine. &nbsp;Renal impairment and symptomatic hypocalcaemia (Trousseau&#39;s and Chvostek&#39;s signs) have been observed during concurrent treatment with Foscavir and i.v. pentamidine. &nbsp;Abnormal renal function has been reported in connection with the use of Foscavir in combination with ritonavir and/or saquinavir.</p><p dir="ltr"><em>&nbsp;</em></p><p dir="ltr">Due to the potential increased risk of QT prolongation and torsade de pointes, Foscavir should be used with caution with drugs known to prolong QT interval, notably class IA (e.g. quinidine) and III (e.g. amiodarone, sotalol), antiarrhythmic agents or neuroleptic drugs. Close cardiac monitoring should be performed in cases of co-administration.</p><p dir="ltr">&nbsp;</p><p dir="ltr">There is no pharmacokinetic interaction with zidovudine (AZT), ganciclovir, didanosine (ddI), zalcitabine (ddC) or probenecid.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Pharmaceutical interactions (incompatibilities for infusion) are described in section 6.2.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr"><em>Fertility</em></p><p dir="ltr">There are no data available regarding the influence of Foscavir on fertility.</p><p dir="ltr">&nbsp;</p><p dir="ltr">No effects on fertility were observed in animal studies (see section 5.3).</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Women of childbearing potential / contraception in males and females</em></p><p dir="ltr">Women capable of childbearing should use effective contraception methods during Foscavir therapy.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Men treated with Foscavir should not father a child during or up to 6 months after therapy.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Pregnancy</em></p><p dir="ltr">There are no or limited amount of data from the use of foscarnet in pregnant women.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Animal studies are insufficient with respect to reproductive toxicity (see section 5.3).</p><p dir="ltr">&nbsp;</p><p dir="ltr">Foscavir is not recommended during pregnancy.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Lactation</em></p><p dir="ltr">There is insufficient information on the excretion of foscarnet in human milk.&nbsp;</p><p dir="ltr">&nbsp;</p><p dir="ltr">Available pharmacodynamic/toxicological data in animals have shown excretion of foscarnet &nbsp;in milk (for details see section 5.3).</p><p dir="ltr">&nbsp;</p><p dir="ltr">A risk to the newborns/infants cannot be excluded.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Foscavir should not be used during breast-feeding.&nbsp; .</p><p dir="ltr">&nbsp;</p><p dir="ltr">A decision must be made whether to discontinue breast-feeding or to discontinue/abstain from Foscavir therapy taking into account the benefit of breast feeding for the child and the benefit of therapy for the woman.</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Foscavir has moderate influence on the ability to drive and use machines.&nbsp; Due to the disease itself and possible undesirable effects of Foscavir (such as dizziness and convulsions, see section 4.8), the ability to drive and use machines can be impaired.&nbsp; The physician is advised to discuss this issue with the patient, and based upon the condition of the disease and the tolerance of medication, give a recommendation in the individual case.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">The majority of patients who receive Foscavir are severely immuno-compromised and suffering from serious viral infections.&nbsp; Patients&rsquo; physical status, the severity of the underlying disease, other infections and concurrent therapies contribute to adverse events observed during use of Foscavir.</p><p dir="ltr">&nbsp;</p><p dir="ltr">The undesirable effects reported with Foscavir during clinical trials&nbsp; and post-marketing surveillance are shown in the table below. They are listed by System‑Organ Class (SOC) and in order of frequency, using the following convention: very common (&sup3;1/10); common (&sup3;1/100 to &lt;1/10); uncommon (&sup3;1/1,000 to &lt;1/100); rare (&sup3;1/10,000 to &lt;1/1,000); very rare (&lt;1/10,000); not known (cannot be estimated from the available data).</p><p dir="ltr">&nbsp;</p><p dir="ltr">Please note that in these clinical trials, hydration and attention to electrolyte balance was not consistently given; the frequency of some adverse events will be lower when current recommendations are followed (see sections 4.2 and 4.4).&nbsp;</p><p dir="ltr"><strong>&nbsp;</strong></p><p dir="ltr"><strong>Table 2 &nbsp;Frequency of adverse events</strong></p><p dir="ltr"><strong>&nbsp;</strong></p><table border="0" cellspacing="0" cellpadding="0" align="left" dir="ltr" style="width:539px"><thead><tr><td style="vertical-align:top"><p>&nbsp;</p><p>SOC</p></td><td style="vertical-align:top"><p>Frequency</p></td><td style="vertical-align:top"><p>Event</p></td></tr></thead><tbody><tr><td rowspan="3" style="vertical-align:top"><p>&nbsp;</p><p>Blood and lymphatic system disorders</p></td><td style="vertical-align:top"><p>Very common</p></td><td style="vertical-align:top"><p>Granulocytopenia, anaemia</p></td></tr><tr><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Leukopenia, thrombocytopenia, neutropenia</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Pancytopenia</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Immune system disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Sepsis</p></td></tr><tr><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Hypersensitivity (including anaphylactic reactions), anaphylactoid reactions</p></td></tr><tr><td style="vertical-align:top"><p>Endocrine disorders</p></td><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Diabetes insipidus</p></td></tr><tr><td style="vertical-align:top"><p>Metabolism and nutrition disorders</p></td><td style="vertical-align:top"><p>Very common</p></td><td style="vertical-align:top"><p>Decreased appetite, hypokalaemia, hypomagnesaemia, hypocalcaemia</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Hyperphosphataemia, hyponatraemia, hypophosphataemia, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, hypercalcaemia, dehydration</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Acidosis</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Hypernatraemia</p></td></tr><tr><td style="vertical-align:top"><p>Psychiatric disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Aggression, agitation, anxiety, confusional state, depression, nervousness</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Nervous system disorders</p></td><td style="vertical-align:top"><p>Very common</p></td><td style="vertical-align:top"><p>Dizziness, headache, paraesthesia</p></td></tr><tr><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Coordination abnormal, convulsion, hypoaesthesia, muscle contractions involuntary, neuropathy peripheral, tremor</p></td></tr><tr><td style="vertical-align:top"><p>Cardiac disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Palpitations, tachycardia</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Electrocardiogram QT prolonged, ventricular arrhythmia, torsade de pointes</p></td></tr><tr><td style="vertical-align:top"><p>Vascular disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Hypertension, hypotension, thrombophlebitis<sup>a</sup></p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Gastrointestinal disorders</p></td><td style="vertical-align:top"><p>Very common</p></td><td style="vertical-align:top"><p>Diarrhoea, nausea, vomiting</p></td></tr><tr><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Abdominal pain, constipation, dyspepsia, pancreatitis, gastrointestinal haemorrhage</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Oesophageal ulceration</p></td></tr><tr><td style="vertical-align:top"><p>Hepatobiliary disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Hepatic function abnormal</p></td></tr><tr><td rowspan="4" style="vertical-align:top"><p>Skin and subcutaneous disorders</p></td><td style="vertical-align:top"><p>Very common</p></td><td style="vertical-align:top"><p>Rash</p></td></tr><tr><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Pruritus</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Urticaria, angioedema</p></td></tr><tr><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Erythema multiforme, toxic epidermal necrolysis, Stevens Johnson syndrome<sup>b</sup></p></td></tr><tr><td style="vertical-align:top"><p>Musculoskeletal and connective tissue disorders</p></td><td style="vertical-align:top"><p>Common</p><p>Not known</p></td><td style="vertical-align:top"><p>Myalgia</p><p>Muscular weakness, myopathy, myositis, rhabdomyolysis</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p>Renal and urinary disorders</p></td><td style="vertical-align:top"><p>Common</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>Renal impairment, renal failure acute, dysuria, polyuria, proteinuria</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Glomerulonephritis, nephrotic syndrome</p></td></tr><tr><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Renal pain, renal tubular acidosis, crystal nephropathy, haematuria</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p><p>Reproductive system and breast disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Genital discomfort and ulceration<sup>c</sup></p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>General disorders and administration site conditions</p></td><td style="vertical-align:top"><p>Very common</p></td><td style="vertical-align:top"><p>Asthenia, chills, fatigue, pyrexia</p></td></tr><tr><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Malaise, oedema, chest pain<sup>d</sup>, injection site pain, injection site inflammation</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Extravasation</p></td></tr><tr><td style="vertical-align:top"><p>Investigations</p></td><td style="vertical-align:top"><p>Very common</p></td><td style="vertical-align:top"><p>Blood creatinine increased, haemoglobin decreased</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Creatinine renal clearance decreased, electrocardiogram abnormal, gamma-glutamyltransferase increased, alanine aminotransferase increased, aspartate aminotransferase increased, lipase increased</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Amylase increased, blood creatine phosphokinase increased</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr></tbody></table><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p><p dir="ltr"><sup>a </sup>Thrombophlebitis in peripheral veins following infusion of undiluted foscarnet solution has been observed.&nbsp;</p><p dir="ltr"><sup>b</sup> Cases of vesiculobullous eruptions including erythema multiforme, toxic epidermal necrolysis, and Stevens Johnson syndrome have been reported. In most cases, patients were taking other medications that have been associated with toxic epidermal necrolysis or Stevens Johnson syndrome.<sup> </sup></p><p dir="ltr"><sup>c</sup> Foscarnet is excreted in high concentrations in the urine and may be associated with significant irritation and ulceration in the genital area, particularly after prolonged therapy.</p><p dir="ltr"><sup>d</sup> Transient chest pain has been reported as part of infusion reactions to foscarnet.</p><p dir="ltr"><u>&nbsp;</u></p><p dir="ltr">To report any side effect(s):</p><ul dir="ltr"><li><strong><em>Saudi Arabia: </em></strong></li></ul><p dir="ltr">&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" dir="ltr"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p><p><strong>- </strong>The National Pharmacovigilance Centre (NPC)</p><ul><li>Fax: +966-11-205-7662</li><li>Toll free phone: 19999</li><li>E-mail: npc.drug@sfda.gov.sa&nbsp;&nbsp;</li><li>Website: https://ade.sfda.gov.sa/</li></ul><p>&nbsp;</p></td></tr></tbody></table><p dir="ltr">&nbsp;</p><p dir="ltr">&middot;&nbsp;&nbsp; Other GCC States:</p><p dir="ltr">&nbsp;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp; Please contact the relevant competent authority.</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Overdose has been reported during the use of Foscavir, the highest being some 20 times the recommended dose. Some of the cases were relative overdoses, in that the dose of drug used had not been promptly adjusted for a patient experiencing reduced renal function.</p><p dir="ltr">&nbsp;</p><p dir="ltr">There are cases where it has been reported that no clinical sequelae were consequent on the overdose.</p><p dir="ltr">&nbsp;</p><p dir="ltr">The pattern of adverse events reported in association with an overdose of Foscavir is in accordance with the known adverse event profile of the drug.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Haemodialysis increases Foscavir elimination and may be of benefit in relevant cases.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Pharmacotherapeutic group: Antivirals for systemic use; direct acting antivirals; phosphonic acid derivatives, ATC code: J05AD01</p><p dir="ltr">Foscarnet is an antiviral agent with a broad spectrum inhibiting all known human viruses of the herpes group: herpes simplex virus type 1 and 2; human herpes virus 6; varicella zoster virus; Epstein-Barr virus and cytomegalovirus (CMV) and some retroviruses, including human immunodeficiency virus (HIV) at concentrations not affecting normal cell growth.&nbsp; Foscarnet also inhibits the viral DNA polymerase from hepatitis B virus.</p><p dir="ltr">Foscarnet exerts its antiviral activity by a direct inhibition of viral specific DNA polymerase a reverse transcriptase at concentrations that do not affect cellular DNA polymerases.&nbsp; Foscarnet does not require activation (phosphorylation) by thymidine kinase or other kinases and therefore is active <em>in vitro</em> against HSV mutants deficient in thymidine kinase.&nbsp; CMV strains resistant to ganciclovir may be sensitive to foscarnet.&nbsp; Sensitivity test results expressed as concentration of the drug required to inhibit growth of virus by 50% in cell culture (IC50) vary greatly depending on the assay method used and cell type employed.&nbsp; A number of sensitive viruses and their IC50 are listed below.</p><p dir="ltr"><strong>Table 3 &nbsp;Foscarnet inhibition of virus multiplication cell culture</strong></p><table border="0" cellspacing="0" cellpadding="0" dir="ltr"><tbody><tr><td colspan="2" style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Virus</p></td><td style="vertical-align:top"><p>IC50(mm)</p></td></tr><tr><td style="vertical-align:top"><p>CMV</p></td><td style="vertical-align:top"><p>50&ndash;800 *</p></td></tr><tr><td style="vertical-align:top"><p>HSV-1, HSV-2</p></td><td style="vertical-align:top"><p>10&ndash;130</p></td></tr><tr><td style="vertical-align:top"><p>VZV</p></td><td style="vertical-align:top"><p>48&ndash;90</p></td></tr><tr><td style="vertical-align:top"><p>EBV</p></td><td style="vertical-align:top"><p>&lt;500**</p></td></tr><tr><td style="vertical-align:top"><p>HHV-6</p></td><td style="vertical-align:top"><p>49</p></td></tr><tr><td style="vertical-align:top"><p>Ganciclovir resistant CMV</p></td><td style="vertical-align:top"><p>190</p></td></tr><tr><td style="vertical-align:top"><p>HSV - TK Minus Mutant</p></td><td style="vertical-align:top"><p>67</p></td></tr><tr><td style="vertical-align:top"><p>HSV - DNA Polymerase Mutant</p></td><td style="vertical-align:top"><p>5&ndash;443</p></td></tr><tr><td style="vertical-align:top"><p>HIV-1</p></td><td style="vertical-align:top"><p>11&ndash;32</p></td></tr><tr><td style="vertical-align:top"><p>Zidovudine resistant HIV-1</p></td><td style="vertical-align:top"><p>10&ndash;32</p></td></tr></tbody></table><p dir="ltr">*&nbsp;&nbsp;&nbsp;&nbsp; Mean = 269 micrograms<br />**&nbsp;&nbsp; 97% of viral antigen synthesis inhibited at 500 micrograms</p><p dir="ltr">If no clinical response to foscarnet is observed, viral isolates should be tested for sensitivity to foscarnet since naturally resistant mutants may exist or emerge under selective pressure both <em>in vitro</em> and <em>in vivo</em>.</p><p dir="ltr">The mean foscarnet 50% inhibition value for more than one hundred clinical CMV isolates was approximately 270 micrograms/L, while a reversible inhibition of normal cell growth was observed at about 1000 micrograms/L.</p><p dir="ltr">There is no evidence of an increased myelotoxicity when foscarnet is used in combination with zidovudine (AZT).&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Foscarnet is eliminated by the kidneys mainly through glomerular filtration.&nbsp; The plasma clearance after intravenous administration to man varies between 130&ndash;160 ml/min and the renal clearance is about 130&nbsp;ml/min.&nbsp; The half-life is in the order of 2&ndash;4 hours in patients with normal renal function.</p><p dir="ltr">The mean volume of distribution of foscarnet at steady state varies between 0.4&ndash;0.6 L/kg.&nbsp; There is no metabolic conversion of foscarnet and the binding to human plasma proteins is low (&lt;20%).&nbsp; Foscarnet is distributed to the cerebrospinal fluid and concentrations ranging from 10 to 70% of the concurrent plasma concentrations have been observed in HIV‑infected patients.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">The most pronounced effects noted during general toxicity studies performed with foscarnet are perturbation of some serum electrolytes, and kidney and bone changes.</p><p dir="ltr">An observed reduction of serum electrolytes such as calcium and magnesium can be explained by the property of foscarnet to form chelate with divalent metal ions.&nbsp; The reduction of ionised calcium and magnesium is, most probably the explanation to seizures/convulsions seen during and shortly after the infusion of high doses of foscarnet.&nbsp; This reduction may also have a bearing on heart function (e.g. ECG) although the toxicological studies performed did not disclose any such effects.&nbsp; The rate of infusion of foscarnet is critical to disturbances in the homeostasis of some serum divalent cations.</p><p dir="ltr">The mechanism behind the kidney changes e.g. tubular atrophy, mainly confined to juxtamedullary nephrons, is less clear.&nbsp; The changes were noted in all species investigated.&nbsp; It is known that other complex binders of divalent cations (EDTA and biphosphonates) can cause changes of the kidney similar to those of foscarnet.&nbsp; It has been shown that hydration, to induce diuresis, significantly reduces kidney changes during foscarnet treatment.</p><p dir="ltr">&nbsp;</p><p dir="ltr">The bone changes were characterised as increased osteoclast activity and bone resorption.&nbsp; Roughly 20% of the administered drug is taken up into bone and cartilage and deposition is greater in young and growing animals.<strong><em>&nbsp; </em></strong>This effect has only been seen in the dog.&nbsp; The reason to these changes may be that foscarnet, due to the structural similarity to phosphate is incorporated into the hydroxyapatite.&nbsp; Autoradiographic studies showed that foscarnet has a pronounced affinity to bone tissue.&nbsp; Recovery studies revealed that the bone changes were reversible.<strong>&nbsp; </strong>Foscarnet sodium has been demonstrated to adversely affect development of tooth enamel in mice and rats. The effects of this deposition on skeletal development have not been studied.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Mutagenicity studies showed that foscarnet has a genotoxic potential.&nbsp; The possible explanation for the observed effect in the mutagenicity studies is an inhibition of the DNA polymerase in the cell line used.&nbsp; Foscarnet therapeutically acts by inhibition of the herpes virus specific DNA polymerase.&nbsp; The human cellular polymerase is about 100 times less sensitive to foscarnet.&nbsp; The carcinogenicity studies performed did not disclose any oncogenic potential.&nbsp; The information gained from teratogenicity and fertility studies did not reveal any adverse events upon the reproductive process.&nbsp; However, the results are of limited value since the dose levels used in these studies are below or at most similar (75&ndash;150 mg/kg sc) to those used in man for treatment of CMV retinitis.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Water for injection to 1.0 ml</p><p dir="ltr">Hydrochloric acid (E507) q.s to pH 7.4</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">This medicinal product must not be mixed with any other medicinal products except those mentioned in section 4.2.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Foscarnet is not compatible with dextrose 30% solution, amphotericin B, aciclovir sodium, ganciclovir, pentamidine isethionate, trimethoprim‑sulfamethoxazole and vancomycin hydrochloride.&nbsp; Neither is foscarnet compatible with solutions containing calcium.&nbsp; It is recommended that other drugs should not be infused concomitantly in the same line.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Unopened:  2 years. 
Once opened:
From a microbiological point of view, the product should be used immediately.  If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8°C.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Do not store above 25&deg;C.&nbsp; Do not refrigerate.&nbsp; If refrigerated or exposed to temperatures below freezing point precipitation may occur.&nbsp; By keeping the bottle at room temperature with repeated shaking, the precipitate can be brought into solution again.</p><p dir="ltr">For storage conditions after first opening and/or dilution of the medicinal product, see section 6.3.</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Infusion glass bottles of 250&nbsp;ml.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Individually dispensed doses of foscarnet can be aseptically transferred to plastic infusion bags by the hospital pharmacy.&nbsp; The physico-chemical stability of foscarnet and dilutions thereof in equal parts with 0.9% sodium chloride (9&nbsp;mg/ml) or 5% dextrose (50&nbsp;mg/ml) in PVC bags is 7 days.&nbsp; However, diluted solutions should be refrigerated and storage restricted to 24 hours.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Each bottle of Foscavir should only be used to treat one patient with a single infusion.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Accidental skin and eye contact with the foscarnet sodium solution may cause local irritation and burning sensation.&nbsp; If accidental contact occurs, the exposed area should be rinsed with water.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Clinigen Healthcare Ltd.
Pitcairn House
First Avenue
Burton-on-Trent
Staffordshire
DE14 2WW
UK

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                March 2022
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>